Cambridge Enterprise and Qkine Ltd sign deal to drive stem cell and regenerative medicine research

2023-06-27T12:51:19+00:00August 1st, 2017|News|

Cambridge Enterprise and specialist growth factor manufacturer Qkine Ltd sign key licensing deal for Activin A production technology